59
Participants
Start Date
October 15, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
October 14, 2026
Febuxostat
The minimal approved dose of febuxostat is 40 mg/day. We will use 0.5 tablet of febuxostat 40 mg or its placebo.
Seoul National University Bundang Hospital, Seongnam-si
Gachon University Gil Medical Center
OTHER
SMG-SNU Boramae Medical Center
OTHER
Chungnam National University Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
Eulji University Hospital
OTHER
Ajou University Medical Center
UNKNOWN
Seoul National University Hospital
OTHER